U.S. Covid-19 Recovery Hits a Bump as Winter Draws Near
(Bloomberg) -- The U.S.'s two-month run of Covid-19 improvements may be coming to an end, in what's become a seasonal cycle of viral ebb and flow.
That's not to say that conditions will imminently start deteriorating, but they've stopped getting better, much as they did after previous recoveries. Similar to the summer surge of 2020, the 2021 Delta wave peaked in early September, giving way to two straight months of falling cases, hospitalizations and deaths.
Now, the recovery is running out of positive momentum some 60 days in -- a repeat of past patterns.
Â
Many public health experts now believe the U.S. will be living with endemic Covid-19 for the foreseeable future, and the latest numbers don't necessarily mean the U.S. is entering a uniquely dangerous new phase.Â
Some states, particularly in the Northeast, are hoping that very strong vaccination rates will keep the virus at bay. But there are still questions about how immunity wanes over time. So far, the data have been very encouraging for the inoculated population and show strong protection against getting sick enough to be hospitalized, or dying.
But data from U.S. hospitals suggest that improvements in viral transmission may well be fading, at least in some parts of the country. New hospital admissions with confirmed Covid-19 are rising in 13 states, up from 11 a week earlier, according to Department of Health and Human Services data. The increase in admissions appears to be a mix of late brushfires from the earlier Delta wave and new flare-ups.Â
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.